Search Within

Zachary Ray Moore

Formats
  1. Meeting Abstract (12)
  2. Journal Article (4)
  3. Review (1)
Groups
  1. GME, Radiation Oncology (17)
  2. Graduate Medical Education (17)
  3. Radiation Oncology, Department of (17)
  4. Department of Medicine (11)
  5. Division of Subspecialty Medicine (9)
  6. Survivorship Research (9)

More Groups

People
  1. Adam Schmitt (6)
  2. Brandon Imber (6)
  3. Alexander Geyer (5)
  4. Andreas Rimner (5)
  5. Daniel Gomez (5)
  6. Joachim Yahalom (5)

More People

Years
  1. 2025 (3)
  2. 2024 (5)
  3. 2023 (3)
  4. 2022 (3)
  5. 2021 (2)
  6. 2020 (1)
Publications
  1. International Journal of Radiation Oncology, Biology, Physics (6)
  2. Journal of Clinical Oncology (2)
  3. Radiotherapy and Oncology (2)
  4. Annals of Oncology (1)
  5. Blood (1)
  6. Frontiers in Oncology (1)

More Publications

Publishers
  1. Elsevier Inc. (9)
  2. American Society of Clinical Oncology (2)
  3. Oxford University Press (2)
  4. American Medical Association (1)
  5. American Society of Hematology (1)
  6. Frontiers Media S.A. (1)

More Publishers

Results (17)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Innate immune signaling drives late cardiac toxicity following DNA-damaging cancer therapies
    Journal Article

    Shamseddine, A.; Patel, S. H.; Chavez, V.; Moore, Z. R.; Adnan, M.; Di Bona, M.; Li, J.; Dang, C. T.; Ramanathan, L. V.; Oeffinger, K. C.; more...
    Journal of Experimental Medicine (2023)

    Fulltext@MSK | Save
  • Quantification of methylation-specific cardiomyocyte cell-free DNA as an early marker of cardiotoxicity in patients with breast cancer receiving anthracyclines and trastuzumab
    Meeting Abstract

    Moore, Z. R.; Yu, A. F.; Liu, J.; Dang, C. T.; Oeffinger, K. C.; Steingart, R.; Schmitt, A.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Biomarkers associated with pulmonary exacerbations in a prospective, placebo-controlled, randomized trial of nintedanib for the treatment of radiation pneumonitis
    Meeting Abstract

    Moore, Z. R.; Huang, X.; Lobaugh, S.; Geyer, A.; Gelblum, D.; Shepherd, A. F.; Shaverdian, N.; Wu, A. J.; Chaft, J.; Zauderer, M.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Randomized, phase II, placebo-controlled trial of nintedanib for the treatment of radiation pneumonitis
    Meeting Abstract

    Moore, Z. R.; Rimner, A.; Lobaugh, S.; Geyer, A.; Gelblum, D. Y.; Shepherd, A. F.; Shaverdian, N.; Wu, A. J.; Chaft, J. E.; Zauderer, M. G.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Phase II randomized trial to evaluate prednisone taper with or without nintedanib for the treatment of radiation pneumonitis
    Meeting Abstract

    Moore, Z.; Lobaugh, S.; Zhang, Z.; Geyer, A.; Gelblum, D.; Abdulnour, R.; Shepherd, A.; Shaverdian, N.; McCune, M.; Li, H.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • MRI radiomic features of radiation induced cardiac toxicity and the effects of c-GAS/STING signaling
    Meeting Abstract

    Moore, Z. R.; Patel, S.; Adnan, M.; Chavez, V.; Lekaye, C. C.; Shamseddine, A.; Chan, A. T.; Veeraraghavan, H.; Schmitt, A.
    International Journal of Radiation Oncology, Biology, Physics (2021)

    Fulltext@MSK | Save
  • Somatic mutations in colorectal cancer identify patients at high-risk of treatment failure following low-BED spine radiotherapy
    Meeting Abstract

    Moore, Z. R.; Shamseddine, A.; Lis, E.; Higginson, D. S.; Bilsky, M.; Barzilai, O.; Laufer, I.; Yamada, Y.; Schmitt, A.
    International Journal of Radiation Oncology, Biology, Physics (2020)

    Fulltext@MSK | Save